TGFB1 and arthritic joint disease: IL-10, IL-1β, IL-6, MMP-3, TNF-α, COX-2, TGF-β, Caspase-1, MAPK and other targets have been confirmed to play key roles in the treatment of arthritis by CC, and can be used as targets for clinical treatment of arthritis, providing scientific basis for the development of rational targeted drugs for the treatment of arthritis.